Cargando…

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) vaccination on HPV infection and disease. PubMed and Embase were systematically searched for peer-reviewed articles from Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garland, Suzanne M., Kjaer, Susanne K., Muñoz, Nubia, Block, Stan L., Brown, Darron R., DiNubile, Mark J., Lindsay, Brianna R., Kuter, Barbara J., Perez, Gonzalo, Dominiak-Felden, Geraldine, Saah, Alfred J., Drury, Rosybel, Das, Rituparna, Velicer, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967609/ https://www.ncbi.nlm.nih.gov/pubmed/27230391 http://dx.doi.org/10.1093/cid/ciw354

Ejemplares similares

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2015)

Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2016)

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region()
por: Castellsagué, Xavier, et al.
Publicado: (2016)

Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review
por: Mariani, Luciano, et al.
Publicado: (2015)

Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial
por: Ferris, Daron G., et al.
Publicado: (2020)

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
por: Cespedes, Michelle S., et al.
Publicado: (2018)

Plasma gelsolin as a biomarker of inflammation
por: DiNubile, Mark J
Publicado: (2008)

Noninferior Antibiotics: When Is “Not Bad” “Good Enough”?
por: DiNubile, Mark J.
Publicado: (2016)

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
por: Hartwig, Susanne, et al.
Publicado: (2012)

A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men
por: Ellsworth, G.B., et al.
Publicado: (2018)

Intention-to-prevent analyses for estimating human papillomavirus vaccine efficacy in clinical studies
por: Saah, Alfred, et al.
Publicado: (2017)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK
por: Dominiak-Felden, Géraldine, et al.
Publicado: (2013)

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia
por: Catteeuw, Julie V., et al.
Publicado: (2021)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
por: Maldonado, Ivette, et al.
Publicado: (2022)

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
por: Joura, Elmar A, et al.
Publicado: (2012)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
por: Hernandez-Aguado, Juan J., et al.
Publicado: (2022)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2021)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

A case of acute disseminated encephalomyelitis following human papillomavirus quadrivalent vaccination
por: Lee, Mina, et al.
Publicado: (2022)

Treatment of invasive candidiasis with caspofungin in the intensive care unit
por: DiNubile, MJ, et al.
Publicado: (2003)

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
por: Brady, Allison M., et al.
Publicado: (2020)

Delayed Therapy with Plasma Gelsolin Improves Survival in Murine Pneumococcal Pneumonia
por: Yang, Zhiping, et al.
Publicado: (2017)

A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
por: Geier, David A., et al.
Publicado: (2014)

Unexpectedly high burden of rotavirus gastroenteritis in very young infants
por: Clark, H Fred, et al.
Publicado: (2010)

Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study
por: Strandberg, Timo E., et al.
Publicado: (2022)

The rationale for quadrivalent influenza vaccines
por: Ambrose, Christopher S., et al.
Publicado: (2012)

A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination
por: Batmunkh, Tsetsegsaihan, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
por: Aponte-González, Johanna, et al.
Publicado: (2013)

Prevention of Anal Condyloma with Quadrivalent Human Papillomavirus Vaccination of Older Men Who Have Sex with Men
por: Swedish, Kristin A., et al.
Publicado: (2014)

1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014)

Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
por: Schlecht, Nicolas F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_75ai45r35tsdpia7pguuku318h